RAPHAEL OTTENBRITE

City:

MIDLOTHIAN, Virginia

Country:

United States

Published Applications:

Last publication date:

2014-09-11

Top Assignees for applications by RAPHAEL OTTENBRITE

The entities that hold a legal rights for patent applications filed by inventor OTTENBRITE RAPHAEL:

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3 PHILADELPHIA, PA United States
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 1 Philadelphia, PA United States
CEPHALON, INC. 1 FRAZER, PA United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYVANIA 1 PHILADELPHIA, PA United States
JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States
VIRGINIA COMMONWEALTH UNIVERSITY 1 Richmond, VA United States
Emisphere Technologies, Inc. 1 Tarrytown, NY United States
CEPTION THERAPEUTICS, INC. 1 Malvern, PA United States
Fulcrum Pharmaceuticals, Inc. 1 Larchmont, NY United States
Fulcrum Pharmaceuticals, Inc. 1 Las Vegas, NV United States
Fulcrum Pharmaceuticals Inc. 1 Las Vagas, NV United States
Cephalon, Inc. 1 Wilmington, DE United States
THE JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States
Cephalon, Inc. 1 Wilmingotn, DE United States

Recent patent applications by OTTENBRITE RAPHAEL

RAPHAEL OTTENBRITE from MIDLOTHIAN, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-09-11

US20140256803A1

Chemistry; metallurgy

Tumor necrosis factor inhibitors

#2 | 2013-03-21

US20130072562A1

Chemistry; metallurgy

Tumor necrosis factor inhibitors

#3 | 2009-09-03

US20090221527A1

Chemistry; metallurgy

Tumor necrosis factor inhibitors

#4 | 2007-06-21

US20070141022A1

Chemistry; metallurgy

Polymeric delivery agents and delivery agent compounds

#5 | 2005-12-01

US20050267071A1

Chemistry; metallurgy

Inhibitors of coronavirus protease and methods of use thereof

#6 | 2005-06-09

US20050124580A1

Human necessities

β-lactamase inhibitors and methods of use thereof

InventorID:

154564 ⎘